ArticleScientific reports2025
An enzyme/pH dual-responsive supramolecular fluorescent vesicle with tunable size fabricated by europium complex and polypseudorotaxanes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The fluorescent vesicles based on lanthanide ions are considered as an ideal biomimetic optical nanoplatform for simulating biological processes of cell membrane. However, the accurately and controllably adjusting the size of vesicles based on lanthanides while ensuring their fluorescence performance and stability still remains a challenge. Herein, a dual-stimuli-responsive fluorescent supramolecular vesicle with tunable size has been designed based on host-guest interaction and coordinating aggregation. Europium complexes can be encapsulated within supramolecular assemblies by assembling with polypseudorotaxanes (PPRs), which are formed by F127 and carboxymethyl-β-cyclodextrin (CMCD) through host-guest interaction. The fluorescence properties of the europium complexes have been significantly enhanced by confining and shielding them within vesicles. Upon the addition of α-amylase and HCl, the fluorescence intensity of the vesicles will gradually and significantly quench as a result of CMCD degradation and dissociation of the europium complexes. This research presents a convenient method for regulating the size of lanthanide fluorescent vesicles, and the supramolecular vesicles obtained with multi-stimuli response are anticipated to be utilized in the diagnosis of relevant diseases and targeted drug delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.